Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Search by expertise, name or affiliation
Fangfei LI public CV
View Scopus Profile
Fangfei LI, Prof
Assistant Professor
,
Chinese Medicine - Teaching and Research Division
https://orcid.org/0000-0001-8281-6115
Email
fangfeili
hkbu.edu
hk
Accepting PhD Students
2011
2025
Research activity per year
Overview
Fingerprint
Network
Projects / Grants
(4)
Research Output
(57)
Prizes / Awards
(2)
Activities
(10)
Press/Media
(3)
Similar Scholars
(6)
Fingerprint
Dive into the research topics where Fangfei LI is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Ruthenium Complexes
100%
Dinuclear
99%
Aptamer
95%
Antimicrobial
69%
Phen
56%
Escherichia Coli
54%
Antimicrobial Activity
51%
Ruthenium
49%
Staphylococcus Aureus
49%
Osteoclast
45%
Triple-negative Breast Cancer
43%
Paclitaxel
43%
Osteosarcoma
43%
Non-small Cell Lung Cancer (NSCLC)
43%
Sclerostin
43%
Targeted Drug Delivery
40%
Eukaryotic Cells
37%
Pseudomonas Aeruginosa (P. aeruginosa)
36%
Methicillin-resistant S. Aureus
34%
Bone Formation
33%
Minimum Inhibitory Concentration
31%
PARP Inhibitor (PARPi)
30%
Osteoblastic
29%
Programmed Death-ligand 1 (PD-L1)
29%
Nucleolin Aptamer
29%
MiR-214-3p
29%
Breast Cancer Bone Metastasis
29%
Therapeutic Genome Editing
29%
Oligonuclear
29%
Cucurbits
29%
Pancreatic Cancer
29%
Exosomal
29%
Molecular Understanding
29%
Pancreatic Ductal Adenocarcinoma
29%
Iridium Complex
29%
1,10-Phenanthroline
27%
Metal Center
27%
Therapeutic Agents
25%
Tumor Microenvironment
25%
Therapeutic Strategies
24%
MicroRNA
24%
Bacterial Membrane
24%
Triple-negative Breast Cancer Cells
24%
Tumor Growth
23%
Flow Cytometry
22%
Gram-positive
21%
Targeted Therapy
21%
Tumor
20%
In Cancer
19%
Bacteria Cell
19%
Pharmacology, Toxicology and Pharmaceutical Science
Ruthenium Complex
84%
Aptamer
81%
Antiinfective Agent
76%
Neoplasm
54%
Staphylococcus aureus
53%
Escherichia coli
47%
Osteosarcoma
43%
Malignant Neoplasm
39%
Antimicrobial Agent
38%
Tumor Growth
36%
Targeted Drug Delivery
33%
Non Small Cell Lung Cancer
33%
Breast Cancer
33%
Nucleic Acid
30%
Nucleolin
29%
Triple Negative Breast Cancer
29%
Bone Metastasis
29%
Sclerostin
29%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
29%
Cucurbitaceae
29%
Bone Disease
29%
Pancreas Cancer
29%
Paclitaxel
25%
Pseudomonas aeruginosa
23%
Lung Metastasis
22%
Meticillin
21%
Pharmacokinetic
20%
Flow Cytometry
19%
Tumor Microenvironment
19%
Oligonucleotide
18%
Minimum Inhibitory Concentration
18%
Cancer Growth
18%
Metastasis
17%
Chemotherapy
17%
Drug Delivery System
16%
Binding Site
15%
Taraxasterol
14%
Rheumatoid Arthritis
14%
Inflammatory Arthritis
14%
Bone Erosion
14%
Leflunomide
14%
Drug Discovery
14%
Drug
14%
microRNA 214
14%
Ezrin
14%
Programmed Death 1 Ligand 1
14%
Controlled Drug Release
14%
Biological Activity
14%
Carcinoma
14%
Tumor Necrosis Factor Receptor Associated Factor 3
14%
Medicine and Dentistry
Aptamer
48%
Bone Metastasis
29%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
29%
Breast Cancer
29%
Genome Editing
29%
Osteosarcoma
29%
Pancreas Cancer
29%
Osteoclast
21%
Lung Metastasis
20%
microRNA
20%
Targeted Therapy
18%
Osteolysis
18%
Clustered Regularly Interspaced Short Palindromic Repeat
16%
Cas9
16%
Cancer Treatment
16%
Ossification
16%
Tumor Cell
15%
Metastatic Carcinoma
14%
Bone Morphogenetic Protein
14%
Programmed Death-Ligand 1
14%
Triple Negative Breast Cancer
14%
Molecular Therapy
14%
Tumor Necrosis Factor Receptor Associated Factor 3
14%
Ezrin
14%
Vasculotropin A
14%
Drug
14%
Nuclease
14%
Disorders of Calcium Metabolism
14%
Phosphate Metabolism
14%
Carcinoma
14%
High Fat Food
14%
Hydroxysteroid Dehydrogenase
14%
Bone Disease
14%
Metabolomics
14%
Pancreas Adenocarcinoma
14%
Proteomics
14%
Osteoclast Differentiation Factor
14%
Paclitaxel
14%
Chondrocyte
14%
Osteoarthritis
14%
Osteoporosis
14%
Atrophic Gastritis
14%
Drug Therapy
14%
Cancer Associated Fibroblast
14%
Chemokine
14%
microRNA 214
14%
Nucleic Acid
14%
Cell Signaling Pathway
14%
Alpha 1 Antitrypsin
14%
Flavonoid
14%
